Brief: aTyr Pharma - Co And Kyorin Terminate Collaboration Agreement Effective July 30, 2026 - SEC Filing
31/07/2026 22:15
BRIEF-aTyr Pharma - Co And Kyorin Terminate Collaboration Agreement Effective July 30, 2026 - SEC Filing July 31 (Reuters) - aTyr Pharma Inc ATYR.O:
ATYR PHARMA - CO AND KYORIN TERMINATE COLLABORATION AGREEMENT EFFECTIVE JULY 30, 2026 - SEC FILING
ATYR PHARMA - REGAINS EXCLUSIVE GLOBAL RIGHTS TO EFZOFITIMOD - SEC FILING
Source text: [ID:n0001339970-26-000042]
Further company coverage: ATYR.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan